Effect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratio.

[1]  Daniel Steinberg,et al.  Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. , 1988, Archives of internal medicine.

[2]  J. Huttunen,et al.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.

[3]  M. Malloy,et al.  Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia. , 1987, Annals of internal medicine.

[4]  E. Nikkilä,et al.  Current pharmacologic treatment of elevated serum cholesterol. , 1987, Circulation.

[5]  D H Blankenhorn,et al.  Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. , 1987, JAMA.

[6]  J. Stamler,et al.  Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. , 1986, Journal of the American College of Cardiology.

[7]  B Buis,et al.  Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial. , 1985, The New England journal of medicine.

[8]  K. Bailey,et al.  Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacin. , 1984, Circulation.

[9]  S. Kelsey,et al.  The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study. , 1984, Circulation.

[10]  J. Hickman,et al.  Relation between high density lipoprotein cholesterol and coronary artery disease in asymptomatic men. , 1981, The American journal of cardiology.

[11]  W. Raynor,et al.  Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study. , 1981, The New England journal of medicine.

[12]  S. Grundy,et al.  Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man. , 1981, Journal of lipid research.

[13]  C. Packard,et al.  Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism. , 1979, The Journal of clinical investigation.

[14]  W. Kannel,et al.  Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. , 1979, Annals of internal medicine.

[15]  C. Blum,et al.  High density lipoprotein metabolism in man. , 1977, The Journal of clinical investigation.

[16]  M C Hjortland,et al.  Predicting coronary heart disease in middle-aged and older persons. The Framington study. , 1977, JAMA.

[17]  D. Thelle,et al.  THE TROMSØHEART-STUDY HIGH-DENSITY LIPOPROTEIN AND CORONARY HEART-DISEASE: A PROSPECTIVE CASE-CONTROL STUDY , 1977, The Lancet.

[18]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[19]  M Marmot,et al.  Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease. , 1977, The American journal of cardiology.

[20]  S. Isomura,et al.  CONTACT INFECTION FROM LIVE VARICELLA VACCINE RECIPIENTS , 1976, The Lancet.

[21]  J. Stamler.  Clofibrate and niacin in coronary heart disease. , 1975, JAMA.

[22]  G. Miller,et al.  PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.

[23]  J. Gass.  Nicotinic acid maculopathy. , 1973, American journal of ophthalmology.

[24]  L. Carlson,et al.  Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study. , 1972, Lancet.

[25]  A. Keys.  CORONARY HEART DISEASE IN SEVEN COUNTRIES , 1971, The Medical journal of Australia.

[26]  L. Carlson,et al.  The effect of nicotinic acid on the plasma free fatty acid; demonstration of a metabolic type of sympathicolysis. , 2009, Acta medica Scandinavica.